Page last updated: 2024-08-25

bendamustine hydrochloride and Infections

bendamustine hydrochloride has been researched along with Infections in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's9 (81.82)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Abramson, JS; Bartlett, NL; Booth, AM; Brander, DM; Brown, JR; Byrd, JC; Coutre, S; Ding, W; Erba, H; Kuzma, CS; Larson, RA; Little, RF; Litzow, M; Mandrekar, SJ; Nattam, S; Owen, C; Ruppert, AS; Smith, SE; Stone, RM; Woyach, JA1
Cheson, BD; Nair, KS; Penne, M; Sarraf Yazdy, M1
Castillo, JJ; Olszewski, AJ; Reagan, JL1
Farmakiotis, D; Freedman, A; Fung, M; Gu, X; Jacobsen, E; Koo, S; Nguyen, PL; Prestes, D1
Cheson, BD; Gehan, E; Ramzi, P; Ujjani, C; Wang, H; Wang, Y1
Avigdor, A; Aviv, A; Avivi, I; Gafter-Gvili, A; Gurion, R; Kedmi, M; Mizrahi, N; Nagler, A; Perry, C; Raanani, P; Ram, R; Ribakovsky, E; Vidal, L1
Balser, C; Barth, J; Blau, W; Boeck, HP; Brugger, W; Hahn, L; Hinke, A; Kaiser, U; Kauff, F; Losem, C; Mueller, L; Niederle, N; Rummel, M; Sandherr, M; Stauch, M; Vereshchagina, J; von Gruenhagen, U; Weidmann, E; Welslau, M1
Gafter-Gvili, A; Polliack, A1
Gafter-Gvili, A; Gurion, R; Raanani, P; Shpilberg, O; Vidal, L1
Cheson, BD; Cohen, P; Herst, JA; Lemieux, B; Robinson, KS; Schwartzberg, LS; Tulpule, A; van der Jagt, RH; Williams, ME1
Alizadeh, AA; Hosein, PJ; Lossos, IS; Maeda, LS; Warsch, S1

Reviews

2 review(s) available for bendamustine hydrochloride and Infections

ArticleYear
Bendamustine associated immune suppression and infections during therapy of hematological malignancies.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:3

    Topics: Agammaglobulinemia; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Hematologic Neoplasms; Humans; Immune System; Immunosuppressive Agents; Infections; Lymphopenia

2016
Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials.
    Hematological oncology, 2017, Volume: 35, Issue:4

    Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Humans; Infections; Randomized Controlled Trials as Topic

2017

Trials

4 trial(s) available for bendamustine hydrochloride and Infections

ArticleYear
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202.
    Leukemia, 2021, Volume: 35, Issue:10

    Topics: Adenine; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Bendamustine Hydrochloride; Female; Follow-Up Studies; Humans; Hypertension; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Prognosis; Rituximab; Survival Rate

2021
Ofatumumab and bendamustine in previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:4

    Topics: Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Drug Administration Schedule; Fatigue; Female; Humans; Infections; Infusions, Intraventricular; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Retreatment; Treatment Outcome

2015
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
    The Lancet. Oncology, 2016, Volume: 17, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Disease-Free Survival; Female; Humans; Infections; Lymphoma, Mantle-Cell; Male; Middle Aged; Recurrence; Retreatment; Rituximab; Survival Rate; Treatment Outcome; Vidarabine

2016
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-20, Volume: 26, Issue:27

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Female; Gastrointestinal Diseases; Headache; Hematologic Diseases; Humans; Infections; Kaplan-Meier Estimate; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Remission Induction; Rituximab

2008

Other Studies

5 other study(ies) available for bendamustine hydrochloride and Infections

ArticleYear
Extended Follow-up of Patients Treated With Bendamustine for Lymphoid Malignancies.
    Clinical lymphoma, myeloma & leukemia, 2017, Volume: 17, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Female; Follow-Up Studies; Humans; Infections; Leukemia, Lymphoid; Lymphoma; Male; Middle Aged; Retreatment; Retrospective Studies; Treatment Outcome; Young Adult

2017
Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas.
    American journal of hematology, 2018, Volume: 93, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cyclophosphamide; Doxorubicin; Female; Humans; Infections; Lymphoma, B-Cell; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Rituximab; Vincristine

2018
Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 01-07, Volume: 68, Issue:2

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cohort Studies; Female; Humans; Infections; Lymphoma, Non-Hodgkin; Male; Multivariate Analysis; Risk Factors

2019
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study.
    Leukemia & lymphoma, 2016, Volume: 57, Issue:1

    Topics: Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Biomarkers; Female; Hematologic Diseases; Hospitalization; Humans; Incidence; Infections; Israel; Lymphoproliferative Disorders; Male; Middle Aged; Retrospective Studies; Risk Factors

2016
A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Female; Humans; Infections; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Middle Aged; Neutropenia; Nitrogen Mustard Compounds; Retrospective Studies; Thrombocytopenia; Treatment Outcome

2012